Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonid Kagan

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|April 22, 2010
Type I interferon receptor is a primary regulator of target-mediated drug disposition of interferon-beta in miceAnson K Abraham, Leonid Kagan, Sarmishtha Kumar, et al.
Pharmaceutical Research|June 25, 2013
Dual physiologically based pharmacokinetic model of liposomal and nonliposomal amphotericin B dispositionLeonid Kagan, Pavel Gershkovich, Kishor M Wasan, et al.
The AAPS Journal|March 25, 2011
Physiologically based pharmacokinetic model of amphotericin B disposition in rats following administration of deoxycholate formulation (Fungizone®): pooled analysis of published dataLeonid Kagan, Pavel Gershkovich, Kishor M Wasan, et al.
BMC Nephrology|November 23, 2021
Evaluation and enhancement of standard equations for renal function estimation in individuals with components of metabolic diseaseLuigi Brunetti, Hyunmoon Back, Sijia Yu, et al.
Pharmaceutical Research|March 17, 2010
Interspecies scaling of receptor-mediated pharmacokinetics and pharmacodynamics of type I interferonsLeonid Kagan, Anson K Abraham, John M Harrold, et al.
Future Cardiology|April 10, 2024
Associations between vitamin D status, <i>VDR</i> gene polymorphisms and echocardiographic markers in Polish patients with cardiovascular diseaseMohamed Abouzid, Paweł Burchardt, Leonid Kagan, et al.
Toxicologic Pathology|September 23, 2009
Subcutaneous and intraperitoneal lipogranulomas following subcutaneous injection of olive oil in Sprague-Dawley ratsYuval Ramot, Shmulik Ben-Eliahu, Leonid Kagan, et al.
Clinical Oral Investigations|May 1, 2009
A novel sustained-release clotrimazole varnish for local treatment of oral candidiasisRakefet Czerninski, Sagi Sivan, Doron Steinberg, et al.
Pharmaceutical Research|September 3, 2011
Subcutaneous absorption of monoclonal antibodies: role of dose, site of injection, and injection volume on rituximab pharmacokinetics in ratsLeonid Kagan, Michael R Turner, Sathy V Balu-Iyer, et al.
Journal of Pharmaceutical Sciences|October 23, 2023
Target Reserve and Turnover Parameters Determine Rightward Shift of Enalaprilat Potency From its Binding Affinity to the Angiotensin Converting EnzymeVan Anh Nguyen, Li Zhang, Leonid Kagan, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Pharmacology and Experimental Therapeutics|April 22, 2010
Type I interferon receptor is a primary regulator of target-mediated drug disposition of interferon-beta in miceAnson K Abraham, Leonid Kagan, Sarmishtha Kumar, et al.
Pharmaceutical Research|June 25, 2013
Dual physiologically based pharmacokinetic model of liposomal and nonliposomal amphotericin B dispositionLeonid Kagan, Pavel Gershkovich, Kishor M Wasan, et al.
The AAPS Journal|March 25, 2011
Physiologically based pharmacokinetic model of amphotericin B disposition in rats following administration of deoxycholate formulation (Fungizone®): pooled analysis of published dataLeonid Kagan, Pavel Gershkovich, Kishor M Wasan, et al.
BMC Nephrology|November 23, 2021
Evaluation and enhancement of standard equations for renal function estimation in individuals with components of metabolic diseaseLuigi Brunetti, Hyunmoon Back, Sijia Yu, et al.
Pharmaceutical Research|March 17, 2010
Interspecies scaling of receptor-mediated pharmacokinetics and pharmacodynamics of type I interferonsLeonid Kagan, Anson K Abraham, John M Harrold, et al.
Future Cardiology|April 10, 2024
Associations between vitamin D status, <i>VDR</i> gene polymorphisms and echocardiographic markers in Polish patients with cardiovascular diseaseMohamed Abouzid, Paweł Burchardt, Leonid Kagan, et al.
Toxicologic Pathology|September 23, 2009
Subcutaneous and intraperitoneal lipogranulomas following subcutaneous injection of olive oil in Sprague-Dawley ratsYuval Ramot, Shmulik Ben-Eliahu, Leonid Kagan, et al.
Clinical Oral Investigations|May 1, 2009
A novel sustained-release clotrimazole varnish for local treatment of oral candidiasisRakefet Czerninski, Sagi Sivan, Doron Steinberg, et al.
Pharmaceutical Research|September 3, 2011
Subcutaneous absorption of monoclonal antibodies: role of dose, site of injection, and injection volume on rituximab pharmacokinetics in ratsLeonid Kagan, Michael R Turner, Sathy V Balu-Iyer, et al.
Journal of Pharmaceutical Sciences|October 23, 2023
Target Reserve and Turnover Parameters Determine Rightward Shift of Enalaprilat Potency From its Binding Affinity to the Angiotensin Converting EnzymeVan Anh Nguyen, Li Zhang, Leonid Kagan, et al.
Pageof 10